Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Walgreens Boots Alliance    WBA

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/17/2017 08/18/2017 08/21/2017 08/22/2017 08/23/2017 Date
80.89(c) 80.03(c) 80.6(c) 81.28(c) 81.36(c) Last
3 488 421 5 239 292 5 180 988 3 206 809 3 801 594 Volume
-0.46% -1.06% +0.71% +0.84% +0.10% Change
More quotes
Financials ($)
Sales 2017 118 034 M
EBIT 2017 7 188 M
Net income 2017 4 616 M
Debt 2017 8 793 M
Yield 2017 1,85%
Sales 2018 125 025 M
EBIT 2018 7 688 M
Net income 2018 5 238 M
Debt 2018 7 853 M
Yield 2018 1,96%
P/E ratio 2017 19,17
P/E ratio 2018 17,39
EV / Sales2017 0,81x
EV / Sales2018 0,76x
Capitalization 86 977 M
More Financials
Company
Walgreens Boots Alliance, Inc. engages in providing drug store services.The company operates through the following segments: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale.The Retail Pharmacy USA segment engages in pharmacy-led health and beauty retail businesses,... 
Sector
Drug Retailers
Calendar

- No events available -

More about the company
Surperformance© ratings of Walgreens Boots Alliance
Trading Rating : Investor Rating :
More Ratings
Latest news on WALGREENS BOOTS ALLIANCE
03:15p WALGREENS : Earns Best Place to Work for Disability Equality Index
08/21 WALGREENS BOOTS ALLIANCE : California Product Stewardship Council Presents Award..
08/17 WALGREENS BOOTS ALLIANCE : Independent Advisor Alliance Buys 175 Company Stocks ..
08/16 RITE AID CORPORATION (NYSE : RAD) Files An 8-K Other Events
08/16 WALGREENS BOOTS ALLIANCE, INC. : Other Events (form 8-K)
08/16 WALGREENS BOOTS ALLIANCE : Launches Center for Health & Wellbeing Research; Comp..
08/16 WALGREENS BOOTS ALLIANCE : ex-dividend day
08/15 WALGREENS : Launches Center for Health & Wellbeing Research
08/10 WALGREENS BOOTS ALLIANCE : Lawsuit alleges Walgreens overcharges customers with ..
08/09 HAGENS BERMAN : Walgreens Sued for Alleged Hidden Generic Drug Overpricing Schem..
More news
Sector news : Drug Retailers - NEC
08/14 China's Fosun, Shanghai Pharma say bid for stake in U.S. drugmaker Arbor
08/09DJCVS HEALTH : Steps Further Onto Turf Of MDs -- WSJ
08/08DJCVS HEALTH : Moves Deeper Into Doctors' Turf
07/26DJMCKESSON : Shareholders Reject Executive Compensation Packages
07/26 ANTHEM : Express Scripts says any new Anthem contract would be unfavorable
More sector news : Drug Retailers - NEC
4-Traders Strategies on WALGREENS BOOTS ALLIANCE 
2015In an upward trend
2015A steady bullish trend
More Strategies
Latest Tweets
06:18pGould Asset Management LLC CA Buys New Stake in Walgreens Boots Alliance, Inc.. 
05:51pAmerisourceBergen to pay $13.4M to resolve kickback case:  
01:57pAnalyzing AmerisourceBergen Corporation $Holding Co $ABC and Prestige Brand H.. 
12:53pNew deal for Dawson #wba #baggies
4
10:48aMiss the result last night? Here's the match report from @WBA's Carabao Cup w..
2
More tweets
Qtime:274
News from SeekingAlpha
07:00a This Bull's Getting Old, So Where Is The Value? - Revisited
08/22 5 Cheapest Funds For Dividend Investors
08/22 Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2017 Updat..
08/20 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2017 Update
08/17 Walgreens to refile notification forms with the DOJ and FTC by tomorrow, wait..
Chart WALGREENS BOOTS ALLIANCE
Duration : Period :
Walgreens Boots Alliance Technical Analysis Chart | WBA | US9314271084 | 4-Traders
Technical analysis trends WALGREENS BOOTS ALLIANCE
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 93,0 $
Spread / Average Target 14%
EPS Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
George Rollo Fairweather Global Chief Financial Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIANCE-1.79%86 977
CVS HEALTH-1.61%79 048
EXPRESS SCRIPTS HOLDING CO-10.42%35 589
MCKESSON CORPORATION5.57%31 177
CARDINAL HEALTH INC-10.55%20 702
AMERISOURCEBERGEN CORP.1.33%17 360